Accurate monitoring of nanoparticle size and growth is essential to ensure scalability in the development of transfection vectors for gene delivery. This study highlights how Spatially Resolved-DLS ...

SHANGHAI, Nov. 6, 2024 /PRNewswire/ -- Duoning Biotechnology Group ("Duoning") announced a strategic partnership agreement with Branca Bunús Ltd. ("Branca Bunús"). Under this agreement, the two ...

German drugmaker Merck KGaA agreed to buy Mirus Bio for $600 million to build expertise in a critical part of viral vector-based gene therapy production. Merck KGaA is making the purchase through its ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Article Views are the COUNTER-compliant sum of full text article downloads since ...

Recent successes in gene therapies are driving continued expansion of the pipeline. The number of clinical trials using adenoassociated virus (AAV) and lentivirus (LV) vectors is growing each year.

insights from industryJames BradySenior Vice PresidentMaxCyte, Inc. In this interview, NewsMedical talks to James Brady about cell-based therapy and how the field of genetic engineering transformed.

In recent years, AAV manufacturing processes have evolved significantly to not only address the need for later-stage clinical and commercial supplies, but also to address regulatory concerns around ...

Setting up robust and reproducible bioprocesses is a top priority for all biotechnology companies focused on developing life changing AAV-based gene therapies. To do so, innovators crave for ...

Transfection involves the conscious introduction of nucleic acid molecules into eukaryotic cells. Some of the most common examples of transfection include introducing DNA plasmids possessing gene ...

Animal cell-based expression platforms enable the production of complex biomolecules such as recombinant proteins and viral vectors. Although most biotherapeutics are produced in animal cell lines, ...